Government strengthens healthcare delivery in Assam
OPPI seeks policy-level clarifications for reducing treatment costs from Budget 2025
Telangana’s Bid to Achieve Positive Investment Growth
Aragen secures $100 M investment from Quadria Capital
Neuberg Diagnostics secures Rs 940 Cr from Kotak Alt
Integris Health raises primary capital ahead of planned IPO
Hyderabad-based PopVax wins $2 M to accelerate development of influenza vaccine
Primrose Bio collaborates with Serum Institute of India to develop novel multi-antigen vaccine
2024 Review of the Indian life sciences sector
WHO launches $ 1.5 B Health Emergency Appeal
World Health Organization (WHO) Academy opens in Lyon, France
MilliporeSigma invests €290 M in new biosafety testing facility in US
Karnataka | 15 January 2025 | News
JNCASR develops new system for wearable devices that can detect stress
Using silver wire network on a stretchable material, scientists fro...Read more
Telangana | 31 December 2024 | Interviews
What key initiatives and strategic changes is the Telangana government implementing to attract investments in ...Read more
MedTech | 17 January 2025 | News
Medtech manufacturers hail CDSCO move on stopping import of used medical devices
Medical device manufacturers have hailed the clarification by the Central Drugs Standard Control Organization ...Read more
Karnataka | 20 January 2025 | News
Immuneel Therapeutics unveils India’s first global CAR T-cell therapy for Non-Hodgkin’s Lymphoma
In a significant step forward for India’s cancer treat...Read more
Tamil Nadu | 20 January 2025 | News
VFL Sciences announces cooperation with RocGene Technology
Chennai-based VFL Sciences and RocGene Technology, based in China, have s...Read more
People | 09 January 2025 | News
Medanta appoints leading urologist Dr Sanjay Gogoi as Chairman of Renal Care Institute
Reinforcing its leadership in advanced kidney care and transplantation, Medanta has appointed globally renowne...Read more
Academics | 20 January 2025 | News
IIHMR Bangalore and RED Health Academy launch first-of-its-kind PG certificate course
International Institute of Health Management Research (IIHMR...Read more
Text blogs | 31 December 2024 | Views
Key Skills & Salary Trends in Healthcare & Pharma for 2025
Evolving Skillsets The healthcare and pharmaceutical industries are undergoing profound transformations, led ...Read more
Indian Pharma Hits R&D Salvo
Pharma companies are constantly on the quest to discover the next big game-changer drug or therapeutic by leveraging the latest, cutting-edge innovation. While it is notable that biopharma companies eased up on their research and development (R&D) spending in FY 2022-23 after the world was hit by COVID-19- induced economic slowdown, the budget for R&D has witnessed a steady increase. Departing a bit from their traditional drug portfolios, companies are increasingly focusing on R&D in nextgeneration therapies to drive innovation, particularly in complex generics, biosimilars, cell and gene therapies and novel drug delivery systems.
For Feedback, please email us at: communications@mmactiv.com
Ashirwad Bungalow, First floor,
36/A/2, S.No. 270, Pallod Farms,
Near Bank of Baroda, Baner Road,
Pune, Maharashtra, India 411045
Mob : +91-9579069369
Email : communications@mmactiv.com
